摘要
Located in Taizhou city,Zhejiang province,Zhejiang Hisoar Pharmaceutical Co.,Ltd.(Hisoar Pharmaceutical,SZ:002099)was foundedin 1966 and listed in Shenzhen Stock Exchange in 2006.It specializes in the production and distribution of special APIs(active pharmaceu-tical ingredient)and pharmaceutical intermediates.More than 70% of the company’s products are exported overseas.APIs produced conclude human medicine and veterinary medicine,mainly including antibiotics,fine chemicals,antiviral drugs,cardiovascular drugs,anthelminthics,hypoglycemic agents,and the mainproducts include clindamycin series,thiamphenicol series,nicotinic acid series and dimethyl dicarboxylate biphenyl and etc.The finechemicals include medicine intermediate and other customize chemicals.Now the company is developing to cover the veterinary and humanmedicine preparation markets.
Located in Taizhou city, Zhejiang province, Zhejiang Hisoar Pharmaceutical Co., Ltd. (Hisoar Pharmaceutical, SZ: 002099) was founded in 1966 and listed in Shenzhen Stock Exchange in 2006. It specializes in the production and distribution of special APIs (active pharmaceu- tical ingredient) and pharmaceutical intermediates. More than 70% of the company's products are exported overseas. APIs produced conclude human medicine and veterinary medicine, mainly including antibiotics, fine chemicals, antiviral drugs, cardiovascular drugs, anthelminthics, hypoglycemic agents, and the main products include clindamycin series, thiamphenicol series, nicotinic acid series and dimethyl dicarboxylate biphenyl and etc. The fine chemicals include medicine intermediate and other customize chemicals. Now the company is developing to cover the veterinary and human medicine preparation markets.
